TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Complete Eradication of Helicobacter Pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in adenoma detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Eye strain score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Probing pocket depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Bleeding on probing (BOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Paediatric Cerebral Performance Category (PCPC) at 12 months after injury
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Presence of at least one DFI
Endpoint domain: Adverse events/effects
Primary endpoint: Decompensated liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary outcomes
Primary endpoint: Occurrence of hepatocellular carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Enrollment rate of eligible parents
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change to rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: intensive care unit admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage stent coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Satisfied With Current Dressings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Satisfied With Experimental Dressings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean difference in baseline intra-tumoral peak lac/pyr ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Glycaemic Index Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Category Changes in the 7-Ordinal Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in prevalence of risk for malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with treatment emergent serious adverse events (TESAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Induction of post-inflammatory hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percent of Patients with a Device-Related Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in 6 Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality in 1-year after randomization
Endpoint domain: Mortality/survival
Primary endpoint: Diabetic retinopathy severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Major Molecular Response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sick-day saving
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Economic variables
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Number of Participants With the Indicated Type of Adverse Events for PEGPH20 and Docetaxel
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of PEGPH20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of human cases with positive stool examination for fasciola eggs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of Patients Who Discontinue Prior to Documented Progression of Disease (PD) or Death
Endpoint domain: Mortality/survival
Primary endpoint: Oral Health Impact Profile (OHIP 14)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sialometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thonsom xerostomy test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on lexical assessments
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Passive Range of Motion of Shoulder in Shoulder External Rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Passive Range of Motion of Shoulder in Shoulder Abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: questionnaire score >80%
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family Burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Expressed emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of postoperative hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: changes in fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Body Mass Index loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completion of ISEO Fitness and Nutrition Curriculum
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-management Skills
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Total dose of propofol and remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ibuprofen concentration in blood serum (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent awake and time to fall asleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from Baseline Motor Control & Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Corticospinal Excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Leucine requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of muscle or joint pain/stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Seropositive rate of EV71 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seropositive rate of anti-HBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum bactericidal antibody rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Periodontal Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Yale Brown Compulsive Scale (CY-BOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choriocapillaris flow area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial wall strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of primary chemotherapy courses until B-hCG < 5 MU/ML
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of surgical operations performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients with high risk of pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hand muscle overflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin A1C (A1C) at Week 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mosquito infection incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Pleasantness judgments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Colony forming Unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Apathy Evaluation Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage Change in Energy Expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nitrogen washout
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Brody 2 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAFLD reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: L-dopa efficacy duration on UPDRS motor scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inter-evaluator agreement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intra-evaluator agreement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Oxygen saturation measured by pulse oximetry (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Breath promoting success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Relative risk of uncomplicated peptic ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global myocardial work efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of women who accept vs decline Truvada at Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to Truvada of women randomized to enhanced counseling vs standard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active and inactive lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality after FLaPp® prosthesis
Endpoint domain: Mortality/survival
Primary endpoint: Evaluation of pain after FLaPp® prosthesis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Biopsy-proven acute rejection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Survival of transplanted kidney
Endpoint domain: Mortality/survival
Primary endpoint: Number of drug-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Tracheal Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urogenital Distress Inventory-6 (UDI-6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) -Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained smoking abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delay before solid food tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: First stool recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: First-time clinical diagnosis of heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of peripheral venous catheterization attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concentration of curcumin in normal and cancerous tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: All-cause mortality within 90 days of study drug administration
Endpoint domain: Mortality/survival
Primary endpoint: Time Used to Walk 20 m at Maximal Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS Scores
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Eradication of H.Pylori Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absence of Significant Gastric Abnormality Post-treatment (Initial Phase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Need for Renal Artery Intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decrease in Systolic and Diastolic Blood Pressure of ≥10 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional Connectivity Strengths of Neural Networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence to lipid lowering therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in the Levels of MPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in the Cellular Origin of MPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generation of T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Motor Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hoogland scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-time effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammatory factors in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: coagulation factors in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: exit-site infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Low Back Pain Numerical Rating Scale (LBP NRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxic death attributable to complications of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: fractional decrement in interictal epileptiform discharges (ID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Colonic Compliance at Pressure at Half-Maximum Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of partners tested for HIV
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of newly diagnosed HIV positive people
Endpoint domain: Mortality/survival
Primary endpoint: Number of residual stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Median time of overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients diagnosed with acute myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalisation for COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hospitalisation for primary cardiac cause
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of awake time per day in an OFF state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS microglial activation measured by [11C]-DAA1106 binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: iPFS (intraprogressional-free survival)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with minor, clinically relevant non-major and major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with composite endpoint of cardiac death, myocardial infarction, re-revascularization or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Length of skin and fascial incisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frequency, rate and severity of solicited and unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, rate and severity of Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Glycaemic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: maximal tolerated dose of volasertib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in the Pediatric Asthma Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Correlation of capillary and venous blood results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinically-indicated major adverse cardiac events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in work of breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Critical body weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time maximum concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of laboratory-confirmed COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Early detection of neonatal sepsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in willingness to engage in unprotected sex
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in willingness to hook up against own wishes
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in intentions to use contraception/protection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in intentions to engage in sexual activity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall post-operative bleeding incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sleep patterns as measured by OURA ring
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Efficacy of Advanced Care Planning program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 18Fludeoxyglucose Positron emission computed tomography scan (18FDG PET-CT scan)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative number of prescriptions of first line antimicrobials
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Objective response rate by RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective overall response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular risk factors (obesity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular risk factors (hypertension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular risk factors (hyperglycemia and dyslipidemia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of adherence to medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of AN2690
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of AN2690 in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupil size after mydriatics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Glucose Total Area Under the Concentration Curve 0 to 2 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Advanced fibrosis in NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Success rate of interventions to stop bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers of patients who needs rescue treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Karnofsky's scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline speed of eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful guidewire insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: resorption of intraretinal cystoid changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication rate of ischemic colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Colon Arrival Time (CAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of participants utilizing the application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: freedom from any atrial arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes